scPharmaceuticals Inc. (2SX.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:47AM CEST. Market open.
| Previous Close | 4.3200 |
| Open | 4.1000 |
| Bid | 4.1200 x 0 |
| Ask | 4.2000 x 0 |
| Day's Range | 4.1000 - 4.1000 |
| 52 Week Range | 4.0000 - 10.9000 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 147.823M |
| Beta (5Y Monthly) | 0.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
scPharmaceuticals Inc. ( NASDAQ:SCPH ) shareholders might be concerned after seeing the share price drop 23% in the...
- Insider Monkey
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48. SCPH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to scPharmaceuticals Fourth Quarter and […]
- GuruFocus.com
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
Sequential Revenue Growth and R&D Advancements Mark Year-End Highlights
© 2024 Yahoo. All rights reserved.